Overexpression of PTEN enhances the sensitivity of human hepatocellular carcinoma HepG2 cells to gefitinib

Tao Tian,Yujuan Yang,Xiao Fu,Hongqing Wen,Kejun Nan,Zhiping Ruan

DOI: https://doi.org/10.3969/j.issn.1672-4992.2016.02.005

2016-01-01

Journal of Modern Oncology

Abstract:Objective:To explore the effect of PTEN overexpression on sensitivity of human hepatocellular carcino-ma HepG2 cells to gefitinib and its molecular mechanism. Methods:The wildtpye PTEN,phosphatase - deficient PTEN mutant and empty vector(pcDNA3. 1)were transducted into HepG2 cells by liposome transfection. The effect of PTEN on the sensitivity and cell apoptosis of transfected HepG2 cells treated by gefitinib were detected by MTT as-say and FACS assay. The expression of PTEN,Akt,pAkt,Caspase - 3 of transfected HepG2 was detected by Western blot. Results:Compared to HepG2 cells transfected into pcDNA3. 1,the sensitivity of HepG2 cells transfected into PTEN to gefitinib significantly increased( P < 0. 05). Meanwhile,apoptosis rates of HepG2 cells transfected into PTEN treated by gefitnib for 48h were significantly increased. Overexpression of PTEN was able to inhibit phosphoryl-ation of Akt and promote expression of Caspase - 3. However,HepG2 cells transfected into phosphatase - deficient PTEN mutant lost the above biological behaviors. Conclusion:PTEN could enhance the sensitivity of HepG2 cells to gefitinib by inhibiting Akt signal pathway and inducing apoptosis.